Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Roche,Vismodegib,"Basal cell carcinoma, locally advanced or metatastic",Vismodegib,Options for investment,,Oncology Agents and Immunosuppressants
